Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kimber

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMJ Neurology Open|March 8, 2021
Progressive cranial neuropathy and uterine involvement in myeloid sarcomaAnthony Khoo, Thomas Kimber, Penelope Cohen, et al.
BMJ Neurology Open|December 29, 2021
Driving restrictions following deep brain stimulation surgeryAndrew Roy Charmley, Thomas Kimber, Neil Mahant, et al.
Practical Neurology|February 17, 2025
Convexity subarachnoid haemorrhage from a cerebral dural arteriovenous fistula presenting with low back painJasmin Chau Minh Le, Jeng Swen Ng, Stephen Bacchi, et al.
Frontiers in Psychology|March 5, 2026
Christian religion and spirituality in eating disorder development, experience, and recovery: an exploration of lived experience in Australia and New ZealandHayley Thomas, Clare O'Callaghan, Megan Best, et al.
Internal Medicine Journal|February 15, 2017
Practical approaches to commencing device-assisted therapies for Parkinson disease in AustraliaDavid R Williams, Andrew H Evans, Victor S C Fung, et al.
Neurology and Therapy|December 1, 2025
Foslevodopa/Foscarbidopa in Younger Patients Earlier Within Advanced Parkinson's Disease: Post Hoc Analysis of a Randomized TrialAngelo Antonini, Bruno Bergmans, Drew S Kern, et al.
Neurology and Therapy|October 4, 2025
Improvement in Motor Consistency and Stability with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Post Hoc Analysis of Two Phase 3 Clinical TrialsRajesh Pahwa, Jason Aldred, Michael J Soileau, et al.
BMJ Open|December 17, 2021
Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trialLucy Vivash, Kelly L Bertram, Charles B Malpas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMJ Neurology Open|March 8, 2021
Progressive cranial neuropathy and uterine involvement in myeloid sarcomaAnthony Khoo, Thomas Kimber, Penelope Cohen, et al.
BMJ Neurology Open|December 29, 2021
Driving restrictions following deep brain stimulation surgeryAndrew Roy Charmley, Thomas Kimber, Neil Mahant, et al.
Practical Neurology|February 17, 2025
Convexity subarachnoid haemorrhage from a cerebral dural arteriovenous fistula presenting with low back painJasmin Chau Minh Le, Jeng Swen Ng, Stephen Bacchi, et al.
Frontiers in Psychology|March 5, 2026
Christian religion and spirituality in eating disorder development, experience, and recovery: an exploration of lived experience in Australia and New ZealandHayley Thomas, Clare O'Callaghan, Megan Best, et al.
Internal Medicine Journal|February 15, 2017
Practical approaches to commencing device-assisted therapies for Parkinson disease in AustraliaDavid R Williams, Andrew H Evans, Victor S C Fung, et al.
Neurology and Therapy|December 1, 2025
Foslevodopa/Foscarbidopa in Younger Patients Earlier Within Advanced Parkinson's Disease: Post Hoc Analysis of a Randomized TrialAngelo Antonini, Bruno Bergmans, Drew S Kern, et al.
Neurology and Therapy|October 4, 2025
Improvement in Motor Consistency and Stability with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Post Hoc Analysis of Two Phase 3 Clinical TrialsRajesh Pahwa, Jason Aldred, Michael J Soileau, et al.
BMJ Open|December 17, 2021
Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trialLucy Vivash, Kelly L Bertram, Charles B Malpas, et al.
Pageof 1